• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,471.95
    176.40 (+0.31%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,560.35(%)
  • Trent
    2,815.00 3,507.32(%)
  • Raymond
    1,024.00 869.05(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 521.75(%)
  • One 97
    1,829.50 1,759.05(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,673.50(%)
  • Britannia Inds.
    4,946.05 5,000.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

SMS Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 25807.0
  • ISIN : INE812G01025
417.45 10 (2.49%)
  • As on 11 Sep 2026 (EOD)

  • Today’s Low

    407.00

  • Today’s High

    421.00

  • Open

    410.55

  • Perv Close

    407.30

  • 52W Low

    242.25

  • 52W High

    447.80

Key Indicators

  • P/E(TTM)

    43.35

  • Mar.Cap (₹Cr.)

    3,909.50

  • Div & Yield %

    0.10

  • Book Value(₹)

    85.93

  • Debt-Equity Ratio

    2.49

  • AGM Date

    10-Sep-2026

  • EPS

    9.67

  • P/E Ratio

    43.35

Financials Ratios

  • Debt-Equity Ratio

    0.54

  • Mar.Cap (₹Cr.)

    3,909.50

  • RONW (%)

    9.87

  • ROCE (%)

    11.69

Score Board

  • Equity (₹ in Cr.)

    9.37

  • BV (₹)

    85.90

  • Sales( ₹ in Cr.)

    886.87

  • NP (in Cr.)

    87.61

  • NP Var(%)

    28.0

  • Div%

    40.0

  • CPS (₹)

    13.60

  • EPS (₹)

    9.40

  • Traded Value (₹ in Lakhs)

    3,925.42

  • 52 Week High

    447.80

  • 52 Week Low

    242.25

  • Price BSE

    419.0

  • Price NSE

    417.00

  • Market Capital( in Cr.)

    3,925.42

  • P/C Ratio

    30.80

  • P/E Ratio

    44.80

  • Price Vs.BV

    9.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 835.55 752.35 554.56 555.34 611.60 453.32
Excise Duty 52.80 43.08 32.51 35.47 48.43 41.37
Net Sales 782.75 709.27 522.05 519.87 563.17 411.95
Other Income 6.22 4.46 4.91 5.20 3.45 5.11
Stock Adjustments 64.81 1.00 -36.08 112.50 -26.73 13.14
Total Income 853.78 714.73 490.88 637.57 539.89 430.20
EXPENDITURE :            
Raw Materials 500.90 425.04 299.52 387.80 313.27 259.50
Power and Fuel Cost 56.76 47.12 35.97 32.58 23.31 18.99
Employee Cost 69.72 56.78 50.08 51.02 41.17 39.35
Other Manufacturing Expenses 29.85 26.52 17.86 22.63 16.19 14.86
Selling and Administration Expenses 47.68 35.68 25.28 21.12 19.02 10.18
Miscellaneous Expenses 2.69 2.14 2.51 2.46 2.34 2.18
Employee Benefit Expenses 69.72 56.78 50.08 51.02 41.17 39.35
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 707.59 593.28 431.23 517.61 415.31 345.06
Operating Profit 146.20 121.45 59.65 119.97 124.59 85.14
Interest 18.54 23.60 21.97 19.16 11.19 12.32
Gross Profit 127.66 97.85 37.68 100.81 113.40 72.82
Depreciation 34.34 31.52 32.13 32.15 22.28 22.07
Profit Before Tax 93.32 66.33 5.55 68.66 91.12 50.75
Current Tax 19.64 15.13 0.00 14.92 16.05 8.94
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 5.30 1.78 1.47 -14.30 14.11 9.13
Reported Net Profit 68.38 49.42 4.08 68.04 60.96 32.69
Extraordinary Items 0.01 0.03 -0.04 0.00 -0.01 -0.03
Adjusted Net Profit 68.37 49.39 4.12 68.04 60.97 32.72
Adjustment below Net Profit -0.51 -0.07 -0.21 0.04 -0.16 -0.09
P & L Balance brought forward 359.04 322.22 320.88 265.35 214.55 197.05
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 13.39 12.54 2.54 12.54 10.00 15.10
P & L Balance carried down 413.52 359.04 322.22 320.88 265.35 214.55
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 40.00 40.00 30.00 30.00 30.00 25.00
Dividend Per Share(Rs) 0.40 0.40 0.30 0.30 0.30 0.25
Earnings Per Share-Unit Curr 7.71 5.84 0.48 8.04 7.20 3.86
Earnings Per Share(Adj)-Unit Curr 7.71 5.84 0.48 8.04 7.20 3.86
Book Value 74.13 64.02 58.49 58.33 50.59 43.40
Book Value(Adj)-Unit Curr 74.13 64.02 58.49 58.33 50.59 43.40

Shareholding Pattern

  • Promoter Group

    68.07%

  • Public Share Holding

    31.93%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 53,678,270 57.32 53,678,270 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 63,745,010 68.07 63,745,010 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 608,105 0.65 608,105 22
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,633,602 2.81 2,633,602 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 18,015 0.02 18,015 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,259,722 3.48 3,259,722 28
2] Non Institution
Bodies Corporate 1,323,119 1.41 1,323,019 133
Clearing Members 226 0.00 226 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,159,461 2.31 2,158,561 405
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,163,166 6.58 6,163,166 8
Individuals holding nominal share capital up to Rs. 1 lakh 16,352,303 17.46 16,133,452 30,901
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 648,523 0.69 648,523 4
Sub Total 26,647,298 28.45 26,427,447 31,454
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 93,652,030 100.00 93,432,179 31,489

Company Background

SMS Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs

  • SMS Pharmaceuticals Ltd
  • BSE Code : 25807.0
  • ISIN : INE812G01025

  • Incorporation Year

    1987

  • Registered Office

    8th Floor Trendset Jayabheri
    Connect Kondapur Serilingampal, Hyderabad,
    Telangana-500084

  • Telephone

  • FAX

  • Chairman

    P Ramesh Babu

  • Managing Director

    P Ramesh Babu

  • Company Secretary

    Thirumalesh Tumma

  • Auditor

    Suryanarayana & Suresh

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285 Domalguda,
    ,
    Mumbai - Hyderabad - 500 029

SMS Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
SMS Pharma. 419.15 788.97 835.55 43.35 12.18
Abbott India 25,272.60 7,217.19 6,929.05 33.26 43.78
Astrazeneca Phar 6,858.65 2,304.07 2,275.58 101.09 27.86
Glaxosmi. Pharma 2,840.80 3,932.76 3,790.20 45.38 58.17
Novartis India 2,425.05 393.10 354.33 61.24 15.94
Cipla 1,380.00 20,102.60 18,979.95 36.27 13.88
Bliss GVS Pharma 703.70 773.53 729.81 65.40 12.51
Amrutanjan Healt 493.80 520.13 502.55 26.45 24.16
Fermenta Biotec. 483.30 474.15 450.25 22.56 18.77
Guj. Themis Bio. 430.80 168.25 165.82 115.19 18.05
Ambalal Sarabhai 41.45 19.52 3.94 76.76 6.77